Market revenue in 2023 | USD 284.5 million |
Market revenue in 2030 | USD 477.6 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Biorepository services |
Fastest growing segment | Biorepository Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biorepository Services, Archiving Solution Services |
Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Biorepository services was the largest segment with a revenue share of 66.36% in 2023. Horizon Databook has segmented the UK clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
The UK is one of the major hubs for biopharmaceuticals companies based in Europe, such as GlaxoSmithKline plc, AstraZeneca, & Novartis, and all clinical trial biorepository & archiving solution providers across Europe have some part of their supply chain going through the UK.
Major clinical supply service players such as DHL, PCI, Alamac, Fisher clinical, and Catalent have distribution and packaging centers in the UK, which provide services across Europe.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account